Fig. 1: Background and catalyst development.
From: Asymmetric N-oxidation catalyzed by bisguanidinium dinuclear oxodiperoxomolybdosulfate
a Chiral N-oxides as medicinal molecules. b Chiral N-oxides as ligands in organocatalysis. c BSA analogs and Flavin-containing monooxygenases and mimics applied in asymmetric N-oxidation. d Organometallics and heteropolymetalates applied in asymmetric N-oxidation. X-ray crystallographic structure of [BG]2+ [(μ-SO4)2Mo2O2(μ-O2)2(O2)2]2- and its utilizing in N-oxidation of alky substituted amines and aryl substituted amines.
